Evidence map›Paper›PMID 32633473›Full record

ArticleESC heart failure2020

Prevalence and prognostic impact of subclinical pulmonary congestion at discharge in patients with acute heart failure.

Mercedes Rivas-Lasarte, Alba Maestro, Juan Fernández-Martínez, Laura López-López, Eduard Solé-González, Miquel Vives-Borrás, Santiago Montero, Nuria Mesado, Maria J Pirla, Sonia Mirabet and 6 more

2 registry-linked trialsOpen access · goldAbstract read
In one paragraph

Article in ESC heart failure, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
3.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05024942 unknown statusnot on this mapstarted 2021, after this paper: background citation

Lung Ultrasound in Aortic Stenosis Patients Undergoing Transcatheter Aortic Valve Replacement: a Prospective Study

TypeobservationalSponsorCatholic University of the Sacred HeartRan2021 to 2022Enrolled150ConditionsTranscatheter Aortic Valve Replacement, Lung Ultrasound, Severe Aortic Valve Stenosis, Pulmonary CongestionArmsTransfemoral TAVR (Transcatheter aortic valve replacement)
NCT06273397 nanot yet recruitingnot on this mapstarted 2024, after this paper: background citation

Acetazolamide or Metolazone in Acute Heart Failure

TypeinterventionalSponsorClinica Alemana de SantiagoRan2024 to 2027Enrolled1,050ConditionsHeart Failure Acute, Decompensated Heart FailureArmsAcetazolamide 250 MG, Metolazone 2.5 MG, Furosemide Injection
3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 73 citations in OpenAlex.

  1. Trial
  2. Guiding Acute Heart Failure Treatment by Point-of-Care Ultrasound: Validation of a Score Combining Lung Ultrasound and Venous Excess Ultrasound.Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine · 2026
    Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Door-to-Diuretic Time and Outcomes in Acute Heart Failure: A Scoping Review.American journal of cardiovascular drugs : drugs, devices, and other interventions · 2025
    Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 1 country.

Mercedes Rivas-LasarteCardiology Department, Hospital de la Santa Creu i Sant Pau, IIb-SantPau, CIBERCV, Universitat Autónoma de Barcelona, Barcelona, Spain.ORCID 0000-0002-8704-3104
Alba MaestroCardiology Department, Hospital de la Santa Creu i Sant Pau, IIb-SantPau, CIBERCV, Universitat Autónoma de Barcelona, Barcelona, Spain.ORCID 0000-0003-1785-3125
Juan Fernández-MartínezCardiology Department, Hospital de la Santa Creu i Sant Pau, IIb-SantPau, CIBERCV, Universitat Autónoma de Barcelona, Barcelona, Spain.
Laura López-LópezCardiology Department, Hospital de la Santa Creu i Sant Pau, IIb-SantPau, CIBERCV, Universitat Autónoma de Barcelona, Barcelona, Spain.
Eduard Solé-GonzálezCardiology Department, Hospital del Mar, Barcelona, Spain.ORCID 0000-0002-5727-9925
Miquel Vives-BorrásCardiology Department, Hospital de la Santa Creu i Sant Pau, IIb-SantPau, CIBERCV, Universitat Autónoma de Barcelona, Barcelona, Spain.
Santiago MonteroCardiology Department, Hospital Germans Trias i Pujol, Universitat Autónoma de Barcelona, Barcelona, Spain.ORCID 0000-0002-0984-3472
Nuria MesadoCardiology Department, Hospital de la Santa Creu i Sant Pau, IIb-SantPau, CIBERCV, Universitat Autónoma de Barcelona, Barcelona, Spain.
Maria J PirlaCardiology Department, Hospital de la Santa Creu i Sant Pau, IIb-SantPau, CIBERCV, Universitat Autónoma de Barcelona, Barcelona, Spain.
Sonia MirabetCardiology Department, Hospital de la Santa Creu i Sant Pau, IIb-SantPau, CIBERCV, Universitat Autónoma de Barcelona, Barcelona, Spain.
Paula FluviàCardiology Department, Hospital Doctor Josep Trueta, Gerona, Spain.
Vicens BrossaCardiology Department, Hospital de la Santa Creu i Sant Pau, IIb-SantPau, CIBERCV, Universitat Autónoma de Barcelona, Barcelona, Spain.
Alessandro SionisCardiology Department, Hospital de la Santa Creu i Sant Pau, IIb-SantPau, CIBERCV, Universitat Autónoma de Barcelona, Barcelona, Spain.ORCID 0000-0003-0843-9512
Eulàlia RoigCardiology Department, Hospital de la Santa Creu i Sant Pau, IIb-SantPau, CIBERCV, Universitat Autónoma de Barcelona, Barcelona, Spain.
Juan CincaCardiology Department, Hospital de la Santa Creu i Sant Pau, IIb-SantPau, CIBERCV, Universitat Autónoma de Barcelona, Barcelona, Spain.ORCID 0000-0003-4819-4265
Jesús Álvarez-GarcíaCardiology Department, Hospital de la Santa Creu i Sant Pau, IIb-SantPau, CIBERCV, Universitat Autónoma de Barcelona, Barcelona, Spain.ORCID 0000-0002-2015-6446
Universitat Autònoma de Barcelona · ESHospital Del Mar · ESHospital Universitari de Girona Doctor Josep Trueta · ES

Funding

Centro de Investigación Biomédica en Red Enfermedades Cardiovaculares CB16/11/00276Daniel Bravo Andreu Private FoundationFondo Europeo de Desarrollo RegionalInstituto de Salud Carlos III CM17/00028Spanish Ministerio de Economia y CompetitividadSpanish Society of Cardiology
6 · The paper itself

Abstract

aimsResidual pulmonary congestion at hospital discharge can worsen the outcomes in patients with heart failure (HF) and can be detected by lung ultrasound (LUS). The aim of this study was to analyse the prevalence of subclinical pulmonary congestion at discharge and its impact on prognosis in patients admitted for acute HF. METHODS AND

resultsThis is a post-hoc analysis of the LUS-HF trial. LUS was performed by the investigators in eight chest zones with a pocket device. Physical exam was subsequently performed by the treating physicians. Primary outcome was a combined endpoint of rehospitalization, unexpected visit for HF worsening or death at 6- month follow-up. Subclinical pulmonary congestion at discharge was defined as the presence of ≥5 B-lines in LUS in absence of rales in the auscultation employing the area under the ROC curve. At discharge, 100 patients (81%) did not show clinical signs of pulmonary congestion. Of these, 41 had ≥5 B-lines. Independent factors related with the presence of subclinical pulmonary congestion were anaemia, higher New York Heart Association (NYHA) class, and N terminal pro brain natriuretic peptide (NT-proBNP). After adjusting by propensity score analysis including age, renal insufficiency, atrial fibrillation, NYHA class, NT-proBNP levels, clinical congestion, and the trial intervention, the presence of subclinical pulmonary congestion at discharge was a risk factor for the occurrence of the primary outcome (hazard ratio 2.63; 95% confidence interval: 1.08-6.41; P = 0.033).

conclusionsUp to 40% of patients considered 'dry' according to pulmonary auscultation presents subclinical congestion at hospital discharge that can be detected by LUS and implies a worse prognosis at 6- month follow-up. Comorbidities, high values of natriuretic peptides, and higher NYHA class are the factors related with its presence.

Indexed as

Heart FailurePatient DischargeHumansLungPrevalencePrognosisHeart failureLung ultrasoundPrognosisPulmonary congestion

Identifiers

PMID32633473
PMCPMC7524099
OpenAlexW3041704883

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.